You are here

Industry News

Advamed Smart Brief

June 27, 2017
An amicus curiae brief has been filed by AdvaMed with the Supreme Court to request review of a lower-court decision in a prod -More
June 27, 2017
Learn more about the amicus brief filed by AdvaMed with the US Supreme Court in the Ethicon v. Huskey case.
June 27, 2017
Acessa Health announced completion of its bankruptcy buyout of Halt Medical, which includes Halt's Acessa radiofrequency abla -More
June 27, 2017
A prospectus has been filed by NanoVibronix in hopes of raising up to $10 million in a round of financing.  -More
June 27, 2017
A round of Series A financing has brought in $3.5 million for eLum Technologies, an early-stage medtech company based in Frem -More
June 27, 2017
Matthew Jewett has been tapped to serve as CEO of Conventus Orthopaedics.  -More
June 27, 2017
Recent Supreme Court decisions dealing with patents have some experts concerned about a weakening of patent holders' rights.  -More
June 27, 2017
Medtronic and health insurer Aetna have agreed to use clinical outcomes as the basis of payment for Medtronic's insulin pump  -More
June 27, 2017
Interpace Diagnostics' ThyraMIR test has obtained a positive coverage policy decision from Premera Blue Cross as a test for t -More
June 27, 2017
The FDA has given Merit Medical Systems de novo clearance for its Embosphere Microspheres for treating symptomatic enlarged p -More

Industry News

RealClear Health
Often undiagnosed, an estimated two to six million people in the United States have a serious heart condition called atrial fibrillation, or AFib. As those living with the disease know, complications from the irregular heartbeat caused by the AFib can be potentially devastating: The average person with AFib is five times more likely to suffer a stroke than someone with a regular heartbeat. Fortunately, there is innovative medical technology available today poised to make a real difference in...
Legal Backgrounder
When a doctor implants a medical device, he or she often requests the presence of a representative of the device manufacturer (a “rep”) in the operating room. Some observers are critical of this practice, demanding thatreps be barred from the O.R. At the same time,some lawyersthink repsin the O.R.should be subject to liability in the court system. This Legal Backgrounder explains why reps often play an important, if limited, role in the O.R., and why that role should not expose reps to lawsuits
Business Wire
ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today the closing of a $36 million Series C financing, including existing convertible notes. The round was led by Philips and UPMC, through its innovation and commercialization arm UPMC Enterprises, with other new and existing investors participating. The funding will support a planned US-based pivotal trial for...
Washington Examiner
Imagine for a moment that you are one of the approximately 44 million women in the U.S. affected by cardiovascular disease, or one of the 24 million with osteoarthritis. You'd want access to the most advanced and effective care. Oftentimes, your doctor would recommend a medical technology or device as an essential component of your treatment – placing a stent in a blocked artery or replacing your knee or hip with a new artificial one, for example. ​​​​​​
Fox Business
Mar. 09, 2017 - AdvaMed CEO Scott Whitaker discusses the impact of the medical device tax on business.​​​​​​